Literature DB >> 9667015

Effects of GDNF on retinal ganglion cell survival following axotomy.

P D Koeberle1, A K Ball.   

Abstract

Recent evidence suggests that approximately 90% of retinal ganglion cells (RGCs) die by the process of apoptosis within 14 days of optic nerve transection. RGCs begin to disappear from the retina between 5 and 7 days postaxotomy when the highest percentage of RGCs show characteristics typical of apoptosis. A single intraocular injection of glial cell-line derived neurotrophic factor (GDNF) given at the time of axotomy resulted in a delay in the initiation of RGC death and increased the densities of surviving RGCs at 7, 10 and 14 days postaxotomy. The mean RGC densities in GDNF treated retinas at 7 (2381 +/- 144), 10 (1561 +/- 117) and 14 (1123 +/- 116) days postaxotomy were significantly higher than that of controls (1835 +/- 82, 835 +/- 272 and 485 +/- 39, respectively). The loss of RGCs was paralleled by increases in TUNEL positive staining in control retinas and a lower percentage of TUNEL positive cells in GDNF treated retinas at 5, 7 and 10 days postaxotomy. These results suggest that GDNF is capable of promoting RGC survival following injury, possibly by interfering with an essential step in apoptosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9667015     DOI: 10.1016/s0042-6989(97)00364-7

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  34 in total

1.  Switching mature retinal ganglion cells to a robust growth state in vivo: gene expression and synergy with RhoA inactivation.

Authors:  Dietmar Fischer; Victoria Petkova; Solon Thanos; Larry I Benowitz
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

2.  Targeting K(V) channels rescues retinal ganglion cells in vivo directly and by reducing inflammation.

Authors:  Paulo D Koeberle; Lyanne C Schlichter
Journal:  Channels (Austin)       Date:  2010-09-25       Impact factor: 2.581

3.  Neuroprotective effect of latanoprost on rat retinal ganglion cells.

Authors:  Hideyo Kudo; Toru Nakazawa; Masahiko Shimura; Hidetoshi Takahashi; Nobuo Fuse; Kenji Kashiwagi; Makoto Tamai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

Review 4.  Current challenges for the advancement of neural stem cell biology and transplantation research.

Authors:  Kristien Reekmans; Jelle Praet; Jasmijn Daans; Veerle Reumers; Patrick Pauwels; Annemie Van der Linden; Zwi N Berneman; Peter Ponsaerts
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

5.  Neuroprotective effects of GDNF-expressing human amniotic fluid cells.

Authors:  Anna Jezierski; Kerry Rennie; Bogdan Zurakowski; Maria Ribecco-Lutkiewicz; Julie Haukenfrers; Abdellah Ajji; Andrée Gruslin; Marianna Sikorska; Mahmud Bani-Yaghoub
Journal:  Stem Cell Rev Rep       Date:  2014-04       Impact factor: 5.739

6.  Death and neuroprotection of retinal ganglion cells after different types of injury.

Authors:  M Vidal-Sanz; M Lafuente; P Sobrado-Calvo; I Selles-Navarro; E Rodriguez; S Mayor-Torroglosa; M P Villegas-Perez
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

7.  Neuroprotection of retinal ganglion cells with GDNF-Loaded biodegradable microspheres in experimental glaucoma.

Authors:  Jian-He Xiao; Mao-Nian Zhang
Journal:  Int J Ophthalmol       Date:  2010-09-18       Impact factor: 1.779

8.  GDNF family ligands trigger indirect neuroprotective signaling in retinal glial cells.

Authors:  Stefanie M Hauck; Norbert Kinkl; Cornelia A Deeg; Magdalena Swiatek-de Lange; Stephanie Schöffmann; Marius Ueffing
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 9.  Impediments to eye transplantation: ocular viability following optic-nerve transection or enucleation.

Authors:  D Ellenberg; J Shi; S Jain; J-H Chang; H Ripps; S Brady; E R Melhem; F Lakkis; A Adamis; D-F Chen; R Ellis-Behnke; R S Langer; S M Strittmatter; D T Azar
Journal:  Br J Ophthalmol       Date:  2009-03-13       Impact factor: 4.638

10.  Glial cell-derived neurotrophic factor gene delivery enhances survival of human corneal epithelium in culture and the overexpression of GDNF in bioengineered constructs.

Authors:  Hong Qi; H David Shine; De-Quan Li; Cintia S de Paiva; William J Farley; Dan B Jones; Stephen C Pflugfelder
Journal:  Exp Eye Res       Date:  2008-10-07       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.